Product name:Ispinesib
CAS:336113-53-2
Molecular Formula:C30H33ClN4O2
Description:Ispinesib, a novel small molecule inhibitor of kinesin spindle protein (KSP) has been the subject of nine Phase II clinical trials and eight Phase I or Ib clinical trials evaluating ispinesib in a variety of both solid and hematologic cancers.